China Biosimilar Drug Industry 2016
- QYR678363
- 164 Pages
- September 2016
- Pharmaceuticals
Firstly, the report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The biosimilar drug market analysis is provided for the international market including development history, competitive landscape analysis, and major regions’ development status.
Secondly, development policies and plans are discussed as well as manufacturing processes and cost structures. This report also states import/export, supply and consumption figures as well as cost, price, revenue and gross margin by regions (North China, East China, etc.), and other regions can be added.
Then, the report focuses on China major leading industry players with information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information. Upstream raw materials, equipment and downstream consumers analysis is also carried out. What’s more, the biosimilar drug industry development trends and marketing channels are analyzed.
Finally, the feasibility of new investment projects is assessed, and overall research conclusions are offered.
In a word, the report provides major statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.
1 Industry Overview 1
1.1 Definition and Specifications of Biosimilar Drug 1
1.2 Classification of Biosimilar Drug 2
1.2.1 Injection 2
1.2.2 Tablets 2
1.2.3 Others 2
1.3 Applications of Biosimilar Drug 2
1.3.1 Ankylosing Spondylitis 2
1.3.2 Tumor 3
1.3.3 Rheumatoid Arthrtis 3
1.3.4 Cardiovascular 3
1.4 Industry Chain Structure of Biosimilar Drug 4
1.5 Industry Policy Analysis of Biosimilar Drug 4
1.6 Industry News Analysis of Biosimilar Drug 5
2 Manufacturing Cost Structure Analysis of Biosimilar Drug 7
2.1 Bill of Materials (BOM) of Biosimilar Drug 7
2.2 Labor Cost Analysis of Biosimilar Drug 7
2.3 Depreciation Cost Analysis of Biosimilar Drug 8
2.4 Manufacturing Cost Structure Analysis of Biosimilar Drug 8
2.5 Manufacturing Process Analysis of Biosimilar Drug 9
3 Technical Data and Manufacturing Plants Analysis of Biosimilar Drug 10
3.1 Capacity and Commercial Production Date of China Key Manufacturers in 2015 10
3.2 Manufacturing Plants Distribution of China Key Biosimilar Drug Manufacturers in 2015 10
3.3 Product, R&D Status and Technology Source of China Biosimilar Drug Key Manufacturers in 2015 11
3.4 Raw Materials Sources Analysis of China Biosimilar Drug Key Manufacturers in 2015 13
4 Capacity, Production and Revenue Analysis of Biosimilar Drug by Regions, Types and Manufacturers 14
4.1 China Capacity, Production and Revenue of Biosimilar Drug by Regions 2011-2016 14
4.2 China and Major Regions Capacity, Production, Revenue and Growth Rate of Biosimilar Drug 2011-2016 24
4.3 China Production and Revenue of Biosimilar Drug by Types 2011-2016 29
4.4 China Capacity, Production and Revenue of Biosimilar Drug by Manufacturers 2011-2016 36
5 Price, Cost, Gross and Gross Margin Analysis of Biosimilar Drug by Regions, Types and Manufacturers 48
5.1 Price, Cost, Gross and Gross Margin Analysis of Biosimilar Drug by Regions 2011-2016 48
5.2 Price and Gross Margin Analysis of Biosimilar Drug by Types 2011-2016 51
5.3 Price, Cost, Gross and Gross Margin Analysis of Biosimilar Drug by Manufacturers 2011-2016 52
6 Consumption Volume, Consumption Value and Sale Price Analysis of Biosimilar Drug by Regions, Types and Applications 57
6.1 China Consumption Volume and Consumption Value of Biosimilar Drug by Regions 2011-2016 57
6.2 China and Major Regions Consumption Volume, Consumption Value and Growth Rate of Biosimilar Drug 2011-2016 65
6.3 China Consumption Volume and Consumption Value of Biosimilar Drug by Applications 2011-2016 68
6.4 Sale Price of Biosimilar Drug by Regions 2011-2016 75
6.5 Sale Price of Biosimilar Drug by Applications 2011-2016 75
6.6 Market Share Analysis of Biosimilar Drug by Different Sale Price Levels 77
7 Supply, Import, Export and Consumption Analysis of Biosimilar Drug 78
7.1 Supply, Consumption and Gap of Biosimilar Drug 2011-2016 78
7.2 China Capacity, Production, Price, Cost, Revenue, Supply and Consumption of Biosimilar Drug 2011-2016 79
7.3 North China Capacity, Production, Price, Cost, Revenue, Supply and Consumption of Biosimilar Drug 2011-2016 80
7.4 East China Capacity, Production, Price, Cost, Revenue, Supply and Consumption of Biosimilar Drug 2011-2016 80
8 Analysis of Biosimilar Drug Industry Key Manufacturers 82
8.1 CP Guojian 82
8.1.1 Company Profile 82
8.1.2 Product Picture and Specifications 83
8.1.3 Capacity, Production, Price, Cost, Gross, and Revenue 84
8.1.4 Contact Information 86
8.2 Biotech 86
8.2.1 Company Profile 86
8.2.2 Product Picture and Specifications 87
8.2.3 Capacity, Production, Price, Cost, Gross, and Revenue 88
8.2.4 Contact Information 89
8.3 Celgen 89
8.3.1 Company Profile 89
8.3.2 Product Picture and Specifications 91
8.3.3 Capacity, Production, Price, Cost, Gross, and Revenue 92
8.3.4 Contact Information 94
8.4 Henlius Biotech 94
8.4.1 Company Profile 94
8.4.2 Product Picture and Specifications 95
8.4.3 Capacity, Production, Price, Cost, Gross, and Revenue 96
8.4.4 Contact Information 98
8.5 Amgen 98
8.5.1 Company Profile 98
8.5.2 Product Picture and Specifications 99
8.5.3 Contact Information 100
8.6 Eli Lilly 100
8.6.1 Company Profile 100
8.6.2 Product Picture and Specifications 102
8.6.3 Contact Information 102
8.7 Novartis 103
8.7.1 Company Profile 103
8.7.2 Product Picture and Specifications 104
8.7.3 Contact Information 104
8.8 Changchun High Tech 105
8.8.1 Company Profile 105
8.8.2 Contact Information 106
8.9 Innovent 106
8.9.1 Company Profile 106
8.9.2 Product Picture and Specification 107
8.9.3 Contact Information 108
9 Marketing Trader or Distributor Analysis of Biosimilar Drug 109
9.1 Marketing Channels Status of Biosimilar Drug 109
9.2 Traders or Distributors of Biosimilar Drug with Contact Information 109
9.3 Ex-work Price, Channel Price and End Buyer Price Analysis of Biosimilar Drug 111
9.4 China Import, Export and Trade Analysis of Biosimilar Drug 111
10 Development Trend of Analysis of Biosimilar Drug 112
10.1 Capacity, Production and Revenue Forecast of Biosimilar Drug by Regions and Types 112
10.1.1 China Capacity, Production and Revenue of Biosimilar Drug by Regions 2016-2021 112
10.1.2 China and Major Regions Capacity, Production, Revenue and Growth Rate of Biosimilar Drug 2016-2021 115
10.1.3 China Capacity, Production and Revenue of Biosimilar Drug by Types 2016-2021 119
10.2 Consumption Volume and Consumption Value Forecast of Biosimilar Drug by Regions, Types and Applications 121
10.2.1 China Consumption Volume and Consumption Value of Biosimilar Drug by Regions 2016-2021 121
10.2.2 China and Major Regions Consumption Volume, Consumption Value and Growth Rate of Biosimilar Drug 2016-2021 125
10.2.3 China Consumption Volume and Consumption Value of Biosimilar Drug by Applications 2016-2021 128
10.3 Supply, Import, Export and Consumption Forecast of Biosimilar Drug 130
10.3.1 Supply, Consumption and Gap of Biosimilar Drug 2016-2021 130
10.3.2 China Capacity, Production, Price, Cost, Revenue, Supply and Consumption of Biosimilar Drug 2016-2021 131
10.3.3 North China Capacity, Production, Price, Cost, Revenue, Supply and Consumption of Biosimilar Drug 2016-2021 132
10.3.4 East China Capacity, Production, Price, Cost, Revenue, Supply and Consumption of Biosimilar Drug 2016-2021 132
11 Industry Chain Suppliers of Biosimilar Drug with Contact Information 134
11.1 Major Raw Materials Suppliers of Biosimilar Drug with Contact Information 134
11.2 Manufacturing Equipment Suppliers of Biosimilar Drug with Contact Information 135
11.3 Major Players of Biosimilar Drug with Contact Information 136
11.4 Key Consumers of Biosimilar Drug with Contact Information 137
11.5 Supply Chain Relationship Analysis of Biosimilar Drug 138
12 New Project Investment Feasibility Analysis of Biosimilar Drug 139
12.1 New Project SWOT Analysis of Biosimilar Drug 139
12.2 New Project Investment Feasibility Analysis of Biosimilar Drug 140
13 Conclusion of the China Biosimilar Drug Industry 2016 141
Figure Picture of Biosimilar Drug 1
Table Product Specifications of Biosimilar Drug 1
Figure Industry Chain Structure of Biosimilar Drug 4
Table Industry Policy of Biosimilar Drug 4
Table Industry News List of Biosimilar Drug 5
Table Bill of Materials (BOM) of Biosimilar Drug 7
Figure APAC Overview of Average Monthly Labor Cost 7
Table Depreciation Cost of Biosimilar Drug 8
Table Manufacturing Cost Structure Analysis of Biosimilar Drug in 2015 8
Figure Manufacturing Process Analysis of Biosimilar Drug 9
Table Capacity (K DDD) and Commercial Production Date of China Biosimilar Drug Key Manufacturers in 2015 10
Table Manufacturing Plants Distribution of China Key Biosimilar Drug Manufacturers in 2015 10
Table Product of China Biosimilar Drug Key Manufacturers in 2015 11
Table R&D Status and Technology Source of China Biosimilar Drug Key Manufacturers in 2015 11
Table R&D Status of Chinese Biosimilar Drug by Other Key Players at the End of 2015 11
Table R&D Status of Chinese Biosimilar Drugs by Products in China at the End of 2015 13
Table Raw Materials Sources Analysis of China and China Biosimilar Drug Key Manufacturers in 2015 13
Table China Capacity (K DDD) of Biosimilar Drug by Regions 2011-2016 14
Figure China Capacity Market Share of Biosimilar Drug by Regions in 2011 14
Figure China Capacity Market Share of Biosimilar Drug by Regions in 2012 15
Figure China Capacity Market Share of Biosimilar Drug by Regions in 2013 15
Figure China Capacity Market Share of Biosimilar Drug by Regions in 2014 16
Figure China Capacity Market Share of Biosimilar Drug by Regions in 2015 16
Figure China Capacity Market Share of Biosimilar Drug by Regions in 2016 17
Table China Production (K DDD) of Biosimilar Drug by Regions 2011-2016 17
Figure China Production Market Share of Biosimilar Drug by Regions in 2011 18
Figure China Production Market Share of Biosimilar Drug by Regions in 2012 18
Figure China Production Market Share of Biosimilar Drug by Regions in 2013 19
Figure China Production Market Share of Biosimilar Drug by Regions in 2014 19
Figure China Production Market Share of Biosimilar Drug by Regions in 2015 20
Figure China Production Market Share of Biosimilar Drug by Regions in 2016 20
Table China Revenue (M $) of Biosimilar Drug by Regions 2011-2016 21
Figure China Revenue Market Share of Biosimilar Drug by Regions in 2011 21
Figure China Revenue Market Share of Biosimilar Drug by Regions in 2012 22
Figure China Revenue Market Share of Biosimilar Drug by Regions in 2013 22
Figure China Revenue Market Share of Biosimilar Drug by Regions in 2014 23
Figure China Revenue Market Share of Biosimilar Drug by Regions in 2015 23
Figure China Revenue Market Share of Biosimilar Drug by Regions in 2016 24
Figure China Capacity (K DDD), Production (K DDD) and Growth Rate of Biosimilar Drug 2011-2016 24
Figure China Capacity Utilization Rate of Biosimilar Drug 2011-2016 25
Figure China Revenue (M $) and Growth Rate of Biosimilar Drug 2011-2016 25
Figure North China Capacity (K DDD), Production (K DDD) and Growth Rate of Biosimilar Drug 2011-2016 26
Figure North China Capacity Utilization Rate of Biosimilar Drug 2011-2016 26
Figure North China Revenue (M $) and Growth Rate of Biosimilar Drug 2011-2016 27
Figure East China Capacity (K DDD), Production (K DDD) and Growth Rate of Biosimilar Drug 2011-2016 27
Figure East China Capacity Utilization Rate of Biosimilar Drug 2011-2016 28
Figure East China Revenue (M $) and Growth Rate of Biosimilar Drug 2011-2016 28
Table China Production (K DDD) of Biosimilar Drug by Types 2011-2016 29
Figure China Production Market Share of Biosimilar Drug by Types in 2011 29
Figure China Production Market Share of Biosimilar Drug by Types in 2012 30
Figure China Production Market Share of Biosimilar Drug by Types in 2013 30
Figure China Production Market Share of Biosimilar Drug by Types in 2014 31
Figure China Production Market Share of Biosimilar Drug by Types in 2015 31
Figure China Production Market Share of Biosimilar Drug by Types in 2016 32
Table China Revenue (M $) of Biosimilar Drug by Types 2011-2016 32
Figure China Revenue Market Share of Biosimilar Drug by Types in 2011 33
Figure China Revenue Market Share of Biosimilar Drug by Types in 2012 33
Figure China Revenue Market Share of Biosimilar Drug by Types in 2013 34
Figure China Revenue Market Share of Biosimilar Drug by Types in 2014 34
Figure China Revenue Market Share of Biosimilar Drug by Types in 2015 35
Figure China Revenue Market Share of Biosimilar Drug by Types in 2016 35
Table China Major Manufacturers Capacity (K DDD) of Biosimilar Drug 2011-2016 36
Table China Capacity Market Share of Biosimilar Drug Major Manufacturers 2011-2016 36
Figure China Capacity Market Share of Biosimilar Drug Major Manufacturers in 2011 37
Figure China Capacity Market Share of Biosimilar Drug Major Manufacturers in 2012 37
Figure China Capacity Market Share of Biosimilar Drug Major Manufacturers in 2013 38
Figure China Capacity Market Share of Biosimilar Drug Major Manufacturers in 2014 38
Figure China Capacity Market Share of Biosimilar Drug Major Manufacturers in 2015 39
Figure China Capacity Market Share of Biosimilar Drug Major Manufacturers in 2016 39
Table China Major Manufacturers Production (K DDD) of Biosimilar Drug 2011-2016 40
Table China Production Market Share of Biosimilar Drug Major Manufacturers 2011-2016 40
Figure China Production Market Share of Biosimilar Drug Major Manufacturers in 2011 41
Figure China Production Market Share of Biosimilar Drug Major Manufacturers in 2012 41
Figure China Production Market Share of Biosimilar Drug Major Manufacturers in 2013 42
Figure China Production Market Share of Biosimilar Drug Major Manufacturers in 2014 42
Figure China Production Market Share of Biosimilar Drug Major Manufacturers in 2015 43
Figure China Production Market Share of Biosimilar Drug Major Manufacturers in 2016 43
Table China Major Manufacturers Revenue (M $) of Biosimilar Drug 2011-2016 44
Table China Revenue Market Share of Biosimilar Drug Major Manufacturers 2011-2016 44
Figure China Revenue Market Share of Biosimilar Drug Major Manufacturers in 2011 45
Figure China Revenue Market Share of Biosimilar Drug Major Manufacturers in 2012 45
Figure China Revenue Market Share of Biosimilar Drug Major Manufacturers in 2013 46
Figure China Revenue Market Share of Biosimilar Drug Major Manufacturers in 2014 46
Figure China Revenue Market Share of Biosimilar Drug Major Manufacturers in 2015 47
Figure China Revenue Market Share of Biosimilar Drug Major Manufacturers in 2016 47
Table Price ($/DDD) of Biosimilar Drug by Regions 2011-2016 48
Figure Price ($/DDD) of Biosimilar Drug by Regions in 2015 48
Table Cost ($/DDD) of Biosimilar Drug by Regions 2011-2016 49
Figure Cost ($/DDD) of Biosimilar Drug by Regions in 2015 49
Table Gross ($/DDD) of Biosimilar Drug by Regions 2011-2016 49
Figure Gross ($/DDD) of Biosimilar Drug by Regions in 2015 50
Table Gross Margin of Biosimilar Drug by Regions 2011-2016 50
Figure Gross Margin of Biosimilar Drug by Regions in 2015 50
Table Price ($/DDD) of Biosimilar Drug by Types 2011-2016 51
Figure Price ($/DDD) of Biosimilar Drug by Types in 2015 51
Table Gross Margin of Biosimilar Drug by Types 2011-2016 51
Figure Gross Margin of Biosimilar Drug by Types in 2015 52
Table Price ($/DDD) of Biosimilar Drug by Manufacturers 2011-2016 52
Figure Price ($/DDD) of Biosimilar Drug by Manufacturers in 2015 53
Table Cost ($/DDD) of Biosimilar Drug by Manufacturers 2011-2016 53
Figure Cost ($/DDD) of Biosimilar Drug by Manufacturers in 2015 54
Table Gross ($/DDD) of Biosimilar Drug by Manufacturers 2011-2016 54
Figure Gross ($/DDD) of Biosimilar Drug by Manufacturers in 2015 55
Table Gross Margin of Biosimilar Drug by Manufacturers 2011-2016 55
Figure Gross Margin ($/DDD) of Biosimilar Drug by Manufacturers in 2015 56
Table China Consumption Volume (K DDD) of Biosimilar Drug by Regions 2011-2016 57
Figure China Consumption Volume Market Share of Biosimilar Drug by Regions in 2011 58
Figure China Consumption Volume Market Share of Biosimilar Drug by Regions in 2012 58
Figure China Consumption Volume Market Share of Biosimilar Drug by Regions in 2013 59
Figure China Consumption Volume Market Share of Biosimilar Drug by Regions in 2014 59
Figure China Consumption Volume Market Share of Biosimilar Drug by Regions in 2015 60
Figure China Consumption Volume Market Share of Biosimilar Drug by Regions in 2016 60
Table China Consumption Value (M $) of Biosimilar Drug by Regions 2011-2016 61
Figure China Consumption Value Market Share of Biosimilar Drug by Regions in 2011 61
Figure China Consumption Value Market Share of Biosimilar Drug by Regions in 2012 62
Figure China Consumption Value Market Share of Biosimilar Drug by Regions in 2013 62
Figure China Consumption Value Market Share of Biosimilar Drug by Regions in 2014 63
Figure China Consumption Value Market Share of Biosimilar Drug by Regions in 2015 63
Figure China Consumption Value Market Share of Biosimilar Drug by Regions in 2016 64
Figure China Consumption Volume (K DDD) and Growth Rate of Biosimilar Drug 2011-2016 65
Figure China Consumption Value (M $) and Growth Rate of Biosimilar Drug 2011-2016 65
Figure North China Consumption Volume (K DDD) and Growth Rate of Biosimilar Drug 2011-2016 66
Figure North China Consumption Value (M $) and Growth Rate of Biosimilar Drug 2011-2016 66
Figure East China Consumption Volume (K DDD) and Growth Rate of Biosimilar Drug 2011-2016 67
Figure East China Consumption Value (M $) and Growth Rate of Biosimilar Drug 2011-2016 67
Table China Consumption Volume (K DDD) of Biosimilar Drug by Applications 2011-2016 68
Figure China Consumption Volume Market Share of Biosimilar Drug by Applications in 2011 68
Figure China Consumption Volume Market Share of Biosimilar Drug by Applications in 2012 69
Figure China Consumption Volume Market Share of Biosimilar Drug by Applications in 2013 69
Figure China Consumption Volume Market Share of Biosimilar Drug by Applications in 2014 70
Figure China Consumption Volume Market Share of Biosimilar Drug by Applications in 2015 70
Figure China Consumption Volume Market Share of Biosimilar Drug by Applications in 2016 71
Table China Consumption Value (M $) of Biosimilar Drug by Applications 2011-2016 71
Figure China Consumption Value Market Share of Biosimilar Drug by Applications in 2011 72
Figure China Consumption Value Market Share of Biosimilar Drug by Applications in 2012 72
Figure China Consumption Value Market Share of Biosimilar Drug by Applications in 2013 73
Figure China Consumption Value Market Share of Biosimilar Drug by Applications in 2014 73
Figure China Consumption Value Market Share of Biosimilar Drug by Applications in 2015 74
Figure China Consumption Value Market Share of Biosimilar Drug by Applications in 2016 74
Table Sale Price ($/DDD) of Biosimilar Drug by Regions 2011-2016 75
Figure Sale Price ($/DDD) of Biosimilar Drug by Regions in 2015 75
Table Sale Price ($/DDD) of Biosimilar Drug by Applications 2011-2016 75
Figure Sale Price ($/DDD) of Biosimilar Drug by Application in 2015 76
Table Market Share of Biosimilar Drug by Different Sale Price Levels 77
Table China Supply, Consumption and Gap of Biosimilar Drug 2011-2016 (K DDD) 78
Table North China Supply, Consumption and Gap of Biosimilar Drug 2011-2016 (K DDD) 78
Table East China Supply, Consumption and Gap of Biosimilar Drug 2011-2016 (K DDD) 78
Table China Capacity (K DDD), Production (K DDD), Price ($/DDD), Cost ($/DDD), Revenue (M $) and Gross Margin of Biosimilar Drug 2011-2016 79
Table China Supply, Import, Export and Consumption of Biosimilar Drug 2011-2016 (K DDD) 79
Table North China Capacity (K DDD), Production (K DDD), Price ($/DDD), Cost ($/DDD), Revenue (M $) and Gross Margin of Biosimilar Drug 2011-2016 80
Table East China Capacity (K DDD), Production (K DDD), Price ($/DDD), Cost ($/DDD), Revenue (M $) and Gross Margin of Biosimilar Drug 2011-2016 80
Table CP Guojian Company Profile 82
Figure Biosimilar Drug Picture and Specifications of CP Guojian 83
Table Biosimilar Drug Capacity (K DDD), Production (K DDD), Price ($/DDD), Cost ($/DDD), Gross ($/DDD), Revenue (M $)and Gross Margin of CP Guojian 2011-2016E 84
Figure Biosimilar Drug Capacity (K DDD), Production (K DDD) and Growth Rate of CP Guojian 2011-2016E 85
Figure Biosimilar Drug Production (K DDD) and China Market Share of CP Guojian 2011-2016E 85
Table Biotech Company Profile 86
Table Biosimilar Drug Picture and Specifications of Biotech 87
Table Biosimilar Drug Capacity (K DDD), Production (K DDD), Price ($/DDD), Cost ($/DDD), Gross ($/DDD), Revenue (M $)and Gross Margin of Biotech 2011-2016E 88
Figure Biosimilar Drug Capacity (K DDD), Production (K DDD) and Growth Rate of Biotech 2011-2016E 88
Figure Biosimilar Drug Production (K DDD) and China Market Share of Biotech 2011-2016E 89
Table Celgen Company Profile 89
Figure Biosimilar Drug Picture and Specifications of Celgen 91
Table Biosimilar Drug Capacity (K DDD), Production (K DDD), Price ($/DDD), Cost ($/DDD), Gross ($/DDD), Revenue (M $)and Gross Margin of Celgen 2011-2016E 92
Figure Biosimilar Drug Capacity (K DDD), Production (K DDD) and Growth Rate of Celgen 2011-2016E 93
Figure Biosimilar Drug Production (K DDD) and China Market Share of Celgen 2011-2016E 93
Table Henlius Biotech Company Profile 94
Figure Biosimilar Drug Picture and Specifications of Henlius Biotech 95
Table Biosimilar Drug Capacity (K DDD), Production (K DDD), Price ($/DDD), Cost ($/DDD), Gross ($/DDD), Revenue (M $)and Gross Margin of Henlius Biotech 2011-2016E 96
Figure Biosimilar Drug Capacity (K DDD), Production (K DDD) and Growth Rate of Henlius Biotech 2011-2016E 97
Figure Biosimilar Drug Production (K DDD) and China Market Share of Henlius Biotech 2011-2016E 97
Table Amgen Company Profile 98
Figure Biosimilar Drug Picture and Specifications of Amgen 99
Table Eli Lilly Company Profile 100
Figure Biosimilar Drug Picture and Specifications of Eli Lilly 102
Table Novartis Company Profile 103
Figure Biosimilar Drug Picture and Specifications of Novartis 104
Table Changchun High Tech Company Profile 105
Table Innovent Company Profile 106
Figure Marketing Channels Status of Biosimilar Drug in 2015 109
Table Traders or Distributors of Biosimilar Drug with Contact Information 109
Table Ex-work Price, Channel Price and End Buyer Price of Biosimilar Drug ($/DDD) in 2011-2016E 111
Table China Import, Export, and Trade of Biosimilar Drug (K DDD) 111
Table China Capacity (K DDD) of Biosimilar Drug by Regions 2016-2021 112
Figure China Capacity Market Share of Biosimilar Drug by Regions in 2021 113
Table China Production (K DDD) of Biosimilar Drug by Regions 2016-2021 113
Figure China Production Market Share of Biosimilar Drug by Regions in 2021 114
Table China Revenue (M $) of Biosimilar Drug by Regions 2016-2021 114
Figure China Revenue Market Share of Biosimilar Drug by Regions in 2021 115
Figure China Capacity (K DDD), Production (K DDD) and Growth Rate of Biosimilar Drug 2016-2021 115
Figure China Capacity Utilization Rate of Biosimilar Drug 2016-2021 116
Figure China Revenue (M $) and Growth Rate of Biosimilar Drug 2016-2021 116
Figure North China Capacity (K DDD), Production (K DDD) and Growth Rate of Biosimilar Drug 2016-2021 117
Figure North China Capacity Utilization Rate of Biosimilar Drug 2016-2021 117
Figure North China Revenue (M $) and Growth Rate of Biosimilar Drug 2016-2021 118
Figure East China Capacity (K DDD), Production (K DDD) and Growth Rate of Biosimilar Drug 2016-2021 118
Figure East China Capacity Utilization Rate of Biosimilar Drug 2016-2021 119
Figure East China Revenue (M $) and Growth Rate of Biosimilar Drug 2016-2021 119
Table China Production (K DDD) of Biosimilar Drug by Types 2016-2021 119
Figure China Production Market Share of Biosimilar Drug by Types in 2021 120
Table China Revenue (M $) of Biosimilar Drug by Types 2016-2021 120
Figure China Revenue Market Share of Biosimilar Drug by Types in 2021 121
Table China Consumption Volume (K DDD) of Biosimilar Drug by Regions 2016-2021 121
Figure China Consumption Volume Market Share of Biosimilar Drug by Regions in 2016 122
Figure China Consumption Volume Market Share of Biosimilar Drug by Regions in 2021 122
Table China Consumption Value (M $) of Biosimilar Drug by Regions 2016-2021 123
Figure China Consumption Value Market Share of Biosimilar Drug by Regions in 2016 123
Figure China Consumption Value Market Share of Biosimilar Drug by Regions in 2021 124
Figure China Consumption Volume (K DDD) and Growth Rate of Biosimilar Drug 2016-2021 125
Figure China Consumption Value (M $) and Growth Rate of Biosimilar Drug 2016-2021 125
Figure North China Consumption Volume (K DDD) and Growth Rate of Biosimilar Drug 2016-2021 126
Figure North China Consumption Value (M $) and Growth Rate of Biosimilar Drug 2016-2021 126
Figure East China Consumption Volume (K DDD) and Growth Rate of Biosimilar Drug 2016-2021 127
Figure East China Consumption Value (M $) and Growth Rate of Biosimilar Drug 2016-2021 127
Table China Consumption Volume (K DDD) of Biosimilar Drug by Applications 2016-2021 128
Figure China Consumption Volume Market Share of Biosimilar Drug by Applications in 2021 128
Table China Consumption Value (M $) of Biosimilar Drug by Applications 2016-2021 129
Figure China Consumption Value Market Share of Biosimilar Drug by Applications in 2021 129
Table China Supply, Consumption and Gap of Biosimilar Drug 2016-2021 (K DDD) 130
Table North China Supply, Consumption and Gap of Biosimilar Drug 2016-2021 (K DDD) 130
Table East China Supply, Consumption and Gap of Biosimilar Drug 2016-2021 (K DDD) 130
Table China Capacity (K DDD), Production (K DDD), Price ($/DDD), Cost ($/DDD), Revenue (M $) and Gross Margin of Biosimilar Drug 2016-2021 131
Table China Supply, Import, Export and Consumption of Biosimilar Drug 2016-2021 (K DDD) 131
Table North China Capacity (K DDD), Production (K DDD), Price ($/DDD), Cost ($/DDD), Revenue (M $) and Gross Margin of Biosimilar Drug 2016-2021 132
Table East China Capacity (K DDD), Production (K DDD), Price ($/DDD), Cost ($/DDD), Revenue (M $) and Gross Margin of Biosimilar Drug 2016-2021 132
Table Major Raw Materials Suppliers of Biosimilar Drug with Contact Information 134
Table Manufacturing Equipment Suppliers of Biosimilar Drug with Contact Information 135
Table Major Players of Biosimilar Drug with Contact Information 136
Table Key Consumers of Biosimilar Drug with Contact Information 137
Figure Supply Chain Relationship Analysis of Biosimilar Drug 138
Table New Project SWOT Analysis of Biosimilar Drug 139
Table New Project Investment Feasibility Analysis of Biosimilar Drug 140
Similar Reports
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
- Publish Date: June 24, 2019
- $1050
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
- Publish Date: February 18, 2019
- $1290
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...
- Publish Date: December 11, 2018
- $1390
